Furthermore, PRDX1, PRDX2, PRDX3, PRDX4, PRDX5, and PRDX6 were altered in 15%, 11%, 10%, 7%, 6%, and 8% of CRC samples, respectively (Figure 8B). This evidence concerns the gene PRDX2 and colorectal carcinoma.